- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ruling Against Obamacare to Get a Second Look
The Appeals Court for the District of Columbia announced Thursday that it would re-hear Halbig v. Burwell en banc, meaning the entire panel of 11 judges will weigh in on the case. There will also be two senior judges who hear the case, but do not vote.
Halbig v. Burwell
The Appeals Court for the District of Columbia announced Thursday that it would re-hear en banc, meaning the entire panel of 11 judges will weigh in on the case. There will also be two senior judges who hear the case, but do not vote.
Halbig
The D.C. Circuit Court previously ruled against the Affordable Care Act in its initial decision. It found that Obamacare subsidies were illegal in the 36 states where the federal government was running the health insurance exchange.
The en banc review has potential to be a big win for Obamacare because it opens up the possibility of the DC Circuit Court reversing its decision. The Fourth Circuit already ruled for Obamacare in a separate, Halbig-like case. If the en banc DC Circuit ruling also rules for the government, that would bring the two appellate courts into agreement on the subsidies’ legality.
For the full story, see: http://bit.ly/WgASXI
Source: Vox
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
